The Alpha-1 Foundation’s (A1F) 7th Global Research Conference & 10th Patient Congress kicks off today in Lisbon, Portugal. With a deep history of international collaboration, A1F is proud to host representatives from over 25 countries who share a drive to cure Alpha-1 Antitrypsin Deficiency (Alpha-1) and to improve the lives of Alphas worldwide. A1F’s Global Program works tirelessly with patients and stakeholders to increase awareness, detection, and access to care for Alphas around the world.
Today, the A1F’s 7th Global Research Conference brings together a multidisciplinary group of scientists and experts to present and discuss novel treatment paradigms in Alpha-1 that will accelerate research toward a cure. The conference agenda has been divided into two segments, The Liver and The Lung, and includes sessions on each topic with expert presentations and robust discussions. A special thank you to Dr. Andrew Wilson, A1F Scientific Director his direction and leadership in making this conference a reality. Thank you to the A1F 7th Global Research Conference Presenters.
Click here to view the agenda.
Similarly, A1F’s 10th Patient Congress is designed to provide a platform for education, discussion, and networking. The program includes research and therapeutic updates, journeys to get augmentation therapy approved and reimbursed, medical collaboration, patient engagement in research, advocacy advancement through public policy and clinical practice, and the importance of awareness, testing, and detection. The overall goal of A1F’s 10th Patient Congress is to empower patients to make informed decisions about care and take part in Alpha-1 research. A highlight of the program’s agenda are the Emerging Therapies in Alpha-1 presentations, updates from A1F industry partners, and robust patient panel discussions. Thank you to the A1G 10th Patient Congress Presenters & Panel Panelists.
Click here to view the agenda.
This event provides an incredible opportunity for Alpha-1 patients, family members, caregivers, researchers, and industry partners around the world to connect. We aim to provide you with the most current and relevant information about Alpha-1 and we encourage attendees to gain a renewed vision and purpose for the task at hand.
A special thank you to A1F’s 7th Global Research Conference & 10th Patient Congress sponsors: AlphaNet, CSL, Grifols, and Takeda, and the Emerging Therapy Sponsors: Beam Therapeutics, Kamada, Sanofi, Takeda, and Wave Life Sciences. We are grateful for your ongoing commitment to Alphas worldwide.
To view the program book, click here.
